Maggie Kalev-Zylinska

Senior Lecturer, Haematologist

University of Auckland

New Zealand

Research Interests

Explore related searches

Professors in New Zealand Professors in Cancer Biology Cancer Biology professors in New Zealand

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Maggie Kalev-Zylinska is a Senior Lecturer and Haematologist at the University of Auckland, New Zealand. Her research focuses on the molecular characterization of blood cancers, particularly acute myeloid leukemia and myeloproliferative neoplasms. Recent publications highlight her investigations into the impacts of socioeconomic factors on leukemia outcomes, as well as the role of specific genetic mutations in hematopoiesis. Dr. Kalev-Zylinska's work aims to advance therapeutic approaches for various hematological conditions.

Articles (14)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (10)

Freda H. Passam

AUSTRALIA

View details

Mark Larance

Senior Lecturer

University of Sydney

AUSTRALIA

View details

Elizabeth Ledgerwood

Senior Lecturer

University of Otago

NEW ZEALAND

View details

James Iain Hearn

Australian National University

AUSTRALIA

View details

Philip Hogg

Professor of Protein Science

University of Sydney

AUSTRALIA

View details

Jean Yang

Professor

University of Sydney

AUSTRALIA

View details

Yunwei Zhang

Macquarie University

AUSTRALIA

View details

Raewyn C. Poulsen

NEW ZEALAND

View details

Young Eun Park

University of Oxford

UNITED KINGDOM

View details

Markus Bender

Professor for Cardiovascular Cell Biology

University Hospital Würzburg

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Maggie Kalev-Zylinska

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

Impact of socioeconomic status on acute myeloid leukemia outcomes in New Zealand’s universal health care

Cohesin <i>rad21</i> mutation dysregulates erythropoiesis and granulopoiesis output within the whole kidney marrow of adult zebrafish

Megakaryocyte maturation involves activation of the adaptive unfolded protein response

Insights into the role of JAK2-I724T variant in myeloproliferative neoplasms from a unique cohort of New Zealand patients

Endoplasmic reticulum protein 5 attenuates platelet endoplasmic reticulum stress and secretion in a mouse model

N-methyl-D-aspartate receptor regulates the circadian clock in megakaryocytic cells and impacts cell proliferation through BMAL1

Advances in molecular characterization of pediatric acute megakaryoblastic leukemia not associated with Down syndrome; impact on therapy development

Deregulated calcium signaling in blood cancer: Underlying mechanisms and therapeutic potential

Advances in molecular characterization of myeloid proliferations associated with Down syndrome

Deletion of Grin1 in mouse megakaryocytes reveals NMDA receptor role in platelet function and proplatelet formation

Ionotropic glutamate receptors in platelets: opposing effects and a unifying hypothesis

The Epidemiology of Myeloproliferative Neoplasms in New Zealand between 2010 and 2017: Insights from the New Zealand Cancer Registry

Ethnic differences in acute promyelocytic leukaemia between New Zealand Polynesian and European patients

Platelet-Reactive Antibodies in Patients after Ischaemic Stroke—An Epiphenomenon or a Natural Protective Mechanism

Collaborators (10)

Freda H. Passam

Mark Larance

Elizabeth Ledgerwood

James Iain Hearn

Philip Hogg

Jean Yang

Yunwei Zhang

Raewyn C. Poulsen

Young Eun Park

Markus Bender

Make your next move.